Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
UNIVERSITY HOSPITAL HRADEC KRALOVE has floated a tender for Medicinal Products Containing Nivolumab and Relatlimab, Cisplatins, Talazopariba, Ivosideniba, Hydroxycarbamide, Aflibercept, Tebentafusp. The project location is Czech Republic and the tender is closing on 29 Sep 2025. The tender notice number is 563459-2025, while the TOT Ref Number is 125349516. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country: Czech Republic
Summary: Medicinal Products Containing Nivolumab and Relatlimab, Cisplatins, Talazopariba, Ivosideniba, Hydroxycarbamide, Aflibercept, Tebentafusp
Deadline: 29 Sep 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 125349516
Document Ref. No.: 563459-2025
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
The subject of the public contract is continuous supplies of medicinal products containing Nivolumab and Relatlimab, cisplatins, talazopariba, ivosidenib, hydroxycarbamide, Aflibercept, tebentafusp for 4 years according to the current needs of the contracting authority.
Nivolumab and Relatlimab products, cisplatins, talazopariba, ivosidenib, hydroxycarbamide, aflibercept, tebentafusp for 4 years according to the current needs of the contracting authority.
Supplies of medicinal products containing Nivolumab and Relatlimab, cisplatins, talazopariba, ivosidenib, hydroxycarbamide, Aflibercept, Tebentafusp for 4 years according to the current needs of the contracting authority.
Nivolumab and Relatlimab medicines, cisplatins, talazopariba, ivosidenib, hydroxycarbamide, Aflibercept, Tebentafusp for 4 years according to the current needs of the contracting authority.
Nivolumab and Relatlimab, cisplatins, talazopariba, ivosidenib, hydroxycarbamide, aflibercept, tebentafusp for 4 years according to the current needs of the contracting authority.
might...
Document Type: Contract Notice
nivolumabu a relatlimabu, cisplatiny, talazoparibu, ivosidenibu, hydroxykarbamidu, afliberceptu, tebentafuspu
Dispatch Date: 2025-08-28
Publish Date: 2025-08-29
Submission Date: 2025-09-29
Documents
Procurement Documents for Czech Republic
Access a comprehensive library of standard procurement documents specific to Czech Republic. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in Czech Republic
Want To Bid in This Tender?
Get Local Agent Support in Czech Republic and 60 More Countries.
View Tenders By
Sign in with Google